Pharmacology · Year 2 · from Pharmacology
Case 1: MRSA Bacteremia with Vancomycin Monitoring
Clinical Scenario
A 58-year-old male with end-stage renal disease on hemodialysis presents with fever and rigors 2 days after his dialysis session.
Patient Demographics
- Age: 58 years
- Sex: Male
- Weight: 85 kg
- Dialysis schedule: Monday, Wednesday, Friday
Chief Complaint
Fever, chills, and feeling "terrible" for 24 hours
History of Present Illness
The patient has ESRD on hemodialysis via a tunneled catheter placed 3 months ago. He developed fevers to 39.5C starting the day after his last dialysis session. He has had rigors, malaise, and decreased appetite. No localizing symptoms of infection. His catheter exit site appears unremarkable.
Physical Examination
- Vital Signs: BP 100/65 mmHg, HR 108 bpm, RR 20, T 39.2C
- General: Ill-appearing, rigors during examination
- HEENT: No oral lesions, no neck stiffness
- Cardiovascular: Tachycardic, no murmurs
- Respiratory: Clear to auscultation
- Catheter site: Tunneled catheter in right IJ, no erythema, drainage, or tenderness
- Skin: No petechiae, no Janeway lesions or Osler nodes
Workup and Results
| Test | Result | Reference Range |
|---|---|---|
| WBC | 18,500/mcL | 4,500-11,000/mcL |
| Blood cultures (2 sets) | Gram-positive cocci in clusters | Negative |
| Lactate | 2.8 mmol/L | 0.5-2.0 mmol/L |
| Procalcitonin | 8.5 ng/mL | <0.25 ng/mL |
Culture identification (Day 2): Methicillin-resistant Staphylococcus aureus (MRSA) Vancomycin MIC: 1 mcg/mL
Diagnosis
MRSA catheter-related bloodstream infection requiring vancomycin therapy with AUC-guided dosing
Antimicrobial Pharmacology Principles Illustrated
- Vancomycin PK/PD: AUC/MIC ratio of 400-600 is the target for optimal efficacy while minimizing nephrotoxicity.
- Renal dosing: Vancomycin is primarily eliminated by the kidneys; in dialysis, dosing is based on dialysis schedule and post-dialysis redosing.
- Loading dose: A loading dose of 25-30 mg/kg achieves therapeutic levels faster in serious infections.
- Therapeutic drug monitoring: AUC-based monitoring is now preferred over trough-only monitoring.
- MIC importance: Higher MIC values (>1 mcg/mL) may require alternative agents due to treatment failure risk.
Treatment
- Vancomycin loading dose: 2 g IV (25 mg/kg rounded)
- Maintenance dosing: 1 g IV during last 1-2 hours of each dialysis session
- AUC monitoring:
- Obtain 2-point PK sampling (post-distribution peak and pre-dialysis trough)
- Target AUC/MIC 400-600
- Catheter management: Remove tunneled catheter if possible; if not, catheter lock therapy
- Transesophageal echocardiogram: Rule out endocarditis in MRSA bacteremia
- Duration: Minimum 4-6 weeks if endocarditis, 2-4 weeks if uncomplicated
- Repeat blood cultures every 24-48 hours until negative
Clinical Image
Scanning electron micrograph of Methicillin-resistant Staphylococcus aureus (MRSA). MRSA carries the mecA gene encoding an altered penicillin-binding protein (PBP2a) with low affinity for beta-lactam antibiotics.
Image Source: Centers for Disease Control and Prevention/Wikimedia Commons License: Public Domain URL: https://commons.wikimedia.org/wiki/File:MRSA_SEM_9994_lores.jpg